Literature DB >> 20976577

Injectable lipid emulsions-advancements, opportunities and challenges.

Ketan Hippalgaonkar1, Soumyajit Majumdar, Viral Kansara.   

Abstract

Injectable lipid emulsions, for decades, have been clinically used as an energy source for hospitalized patients by providing essential fatty acids and vitamins. Recent interest in utilizing lipid emulsions for delivering lipid soluble therapeutic agents, intravenously, has been continuously growing due to the biocompatible nature of the lipid-based delivery systems. Advancements in the area of novel lipids (olive oil and fish oil) have opened a new area for future clinical application of lipid-based injectable delivery systems that may provide a better safety profile over traditionally used long- and medium-chain triglycerides to critically ill patients. Formulation components and process parameters play critical role in the success of lipid injectable emulsions as drug delivery vehicles and hence need to be well integrated in the formulation development strategies. Physico-chemical properties of active therapeutic agents significantly impact pharmacokinetics and tissue disposition following intravenous administration of drug-containing lipid emulsion and hence need special attention while selecting such delivery vehicles. In summary, this review provides a broad overview of recent advancements in the field of novel lipids, opportunities for intravenous drug delivery, and challenges associated with injectable lipid emulsions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20976577      PMCID: PMC3011075          DOI: 10.1208/s12249-010-9526-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  122 in total

1.  Jonathan Roads Symposium Papers. History of parenteral nutrition.

Authors:  Erik Vinnars; Douglas Wilmore
Journal:  JPEN J Parenter Enteral Nutr       Date:  2003 May-Jun       Impact factor: 4.016

2.  Hydrolysis kinetics of phospholipids in thermally stressed intravenous lipid emulsion formulations.

Authors:  C J Herman; M J Groves
Journal:  J Pharm Pharmacol       Date:  1992-07       Impact factor: 3.765

3.  Triglyceride hydrolysis of soy oil vs fish oil emulsions.

Authors:  F L Oliveira; S C Rumsey; E Schlotzer; I Hansen; Y A Carpentier; R J Deckelbaum
Journal:  JPEN J Parenter Enteral Nutr       Date:  1997 Jul-Aug       Impact factor: 4.016

4.  Monounsaturated fatty acid-based lipid emulsions in critically ill patients are associated with fewer complications.

Authors:  Abelardo Garcia-de-Lorenzo
Journal:  Br J Nutr       Date:  2006-05       Impact factor: 3.718

5.  A novel in vitro release method for submicron sized dispersed systems.

Authors:  N Chidambaram; D J Burgess
Journal:  AAPS PharmSci       Date:  1999

6.  Fat emulsion particle size: influence on the clearance rate and the tissue lipolytic activity.

Authors:  O Lutz; Z Meraihi; J L Mura; A Frey; G H Riess; A C Bach
Journal:  Am J Clin Nutr       Date:  1989-12       Impact factor: 7.045

7.  Effects of sphingomyelin and phosphatidylcholine acyl chains on the clearance of triacylglycerol-rich lipoproteins from plasma. Studies with lipid emulsions in rats.

Authors:  T G Redgrave; V Rakic; B C Mortimer; J C Mamo
Journal:  Biochim Biophys Acta       Date:  1992-06-05

8.  Formation and stability of nano-emulsions.

Authors:  Tharwat Tadros; P Izquierdo; J Esquena; C Solans
Journal:  Adv Colloid Interface Sci       Date:  2004-05-20       Impact factor: 12.984

9.  Phosphatidylcholine composition of emulsions influences triacylglycerol lipolysis and clearance from plasma.

Authors:  S B Clark; A Derksen
Journal:  Biochim Biophys Acta       Date:  1987-07-13

10.  Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat.

Authors:  A Tibell; M Larsson; A Alvestrand
Journal:  Transpl Int       Date:  1993-03       Impact factor: 3.782

View more
  29 in total

1.  Computed tomography-guided screening of surfactant effect on blood circulation time of emulsions: application to the design of an emulsion formulation for paclitaxel.

Authors:  Eun-Hye Lee; Soon-Seok Hong; So Hee Kim; Mi-Kyung Lee; Joon Seok Lim; Soo-Jeong Lim
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

2.  A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

Authors:  Luis A Brito; Michelle Chan; Christine A Shaw; Armin Hekele; Thomas Carsillo; Mary Schaefer; Jacob Archer; Anja Seubert; Gillis R Otten; Clayton W Beard; Antu K Dey; Anders Lilja; Nicholas M Valiante; Peter W Mason; Christian W Mandl; Susan W Barnett; Philip R Dormitzer; Jeffrey B Ulmer; Manmohan Singh; Derek T O'Hagan; Andrew J Geall
Journal:  Mol Ther       Date:  2014-07-16       Impact factor: 11.454

Review 3.  Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy.

Authors:  Srinivas Ganta; Meghna Talekar; Amit Singh; Timothy P Coleman; Mansoor M Amiji
Journal:  AAPS PharmSciTech       Date:  2014-02-08       Impact factor: 3.246

4.  Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study.

Authors:  Liziane O F Monteiro; Renata S Fernandes; Caroline M R Oda; Sávia C Lopes; Danyelle M Townsend; Valbert N Cardoso; Mônica C Oliveira; Elaine A Leite; Domenico Rubello; André L B de Barros
Journal:  Biomed Pharmacother       Date:  2017-11-06       Impact factor: 6.529

5.  The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties.

Authors:  Anna Schwendeman; Denis O Sviridov; Wenmin Yuan; Yanhong Guo; Emily E Morin; Yue Yuan; John Stonik; Lita Freeman; Alice Ossoli; Seth Thacker; Salena Killion; Milton Pryor; Y Eugene Chen; Scott Turner; Alan T Remaley
Journal:  J Lipid Res       Date:  2015-06-27       Impact factor: 5.922

6.  Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.

Authors:  Benjamin J Josey; Elizabeth S Inks; Xuejun Wen; C James Chou
Journal:  J Med Chem       Date:  2013-01-30       Impact factor: 7.446

7.  Preparation of intravenous cholesterol tracer using current good manufacturing practices.

Authors:  Xiaobo Lin; Lina Ma; Susan B Racette; William P Swaney; Richard E Ostlund
Journal:  J Lipid Res       Date:  2015-09-28       Impact factor: 5.922

Review 8.  Alternative lipid emulsions in the critically ill: a systematic review of the evidence.

Authors:  William Manzanares; Rupinder Dhaliwal; Brian Jurewitsch; Renee D Stapleton; Khursheed N Jeejeebhoy; Daren K Heyland
Journal:  Intensive Care Med       Date:  2013-06-29       Impact factor: 17.440

9.  Delayed Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Inhibition by Trametinib Attenuates Systemic Inflammatory Responses and Multiple Organ Injury in Murine Sepsis.

Authors:  Joshua A Smith; Philip R Mayeux; Rick G Schnellmann
Journal:  Crit Care Med       Date:  2016-08       Impact factor: 7.598

Review 10.  Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity.

Authors:  Iman Karimzadeh; Hossein Khalili; Shadi Farsaei; Simin Dashti-Khavidaki; Mohammad Mahdi Sagheb
Journal:  Eur J Clin Pharmacol       Date:  2013-01-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.